Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4797 Reports

🤖 AI Analyzed

Recent

📄 Page 231 of 400

Zumiez Inc

10-K March 12, 2026

Key Highlights

Solid financial health with $120 million in cash and minimal long-term debt, dem...
Blue Tomato brand shows resilience and contributes positively to international s...
Effective inventory management helped reduce excess stock despite challenging ma...

Read Analysis

🤖 AI Generated

Federal Home Loan Bank of Topeka

10-K March 12, 2026

Key Highlights

Achieved robust financial performance with significant growth in net interest in...
Maintains a strong and stable financial position with capital levels well above ...
Serves as a reliable, cost-effective funding source for member institutions, lev...

Read Analysis

🤖 AI Generated

Federal Home Loan Bank of Indianapolis

10-K March 12, 2026

Key Highlights

FHLBI delivered strong financial performance in 2025, driven by robust growth in...
Retained earnings grew by $54 million in 2025, reaching a total of $1.478 billio...
Advances to member banks increased by $2 billion, rising from $44 billion in 202...

Read Analysis

🤖 AI Generated

PRECISION BIOSCIENCES INC

10-K March 12, 2026

Key Highlights

Strategic pivot to focus on proprietary ARCUS in vivo gene editing programs (HBV...
Strong reliance on strategic partnerships (Novartis, Imugene, TG Therapeutics) f...
Benefits from incentives like an Orphan Drug Tax Credit Carryforward, aiding dev...

Read Analysis

🤖 AI Generated

AUDIOEYE INC

10-K March 12, 2026

Key Highlights

Robust 18% revenue growth to $35.5 million, driven by a 15% customer base expans...
Significant 30% improvement in net loss to $8.2 million, reflecting enhanced ope...
Unique hybrid AI-plus-human platform provides a strong competitive edge, ensurin...

Read Analysis

🤖 AI Generated

North American Construction Group Ltd.

40-F March 12, 2026

Key Highlights

NACG achieved record revenue of nearly $1.5 billion in 2025, demonstrating stron...
Free Cash Flow significantly increased by 240% to $61.2 million, indicating impr...
The strategic acquisition of Iron Mine Contracting (IMC) positions NACG to becom...

Read Analysis

🤖 AI Generated

Galiano Gold Inc.

40-F March 12, 2026

Key Highlights

Became 100% owner and operator of the Asanko Gold Mine, simplifying operations a...
Achieved 2025 gold production of 125,000 ounces at a competitive All-in Sustaini...
Significantly increased measured and indicated gold resources by 500,000 ounces ...

Read Analysis

🤖 AI Generated

RAPID MICRO BIOSYSTEMS, INC.

10-K March 12, 2026

Key Highlights

Revenue grew 12% to $38.5 million in 2025, driven by a higher mix of recurring r...
Launched Growth Direct® System 2.0 in Q3 2025, securing 15 new orders and receiv...
Successfully expanded into two new European markets, contributing to a 15% incre...

Read Analysis

🤖 AI Generated

Navios Maritime Partners L.P.

20-F March 12, 2026

Key Highlights

Strong financial performance in FY2023 with $1.2 billion revenue (15% increase),...
Significant investment in fleet modernization and decarbonization, committing $7...
Attractive shareholder returns through a $75 million unit repurchase program and...

Read Analysis

🤖 AI Generated

RARE ELEMENT RESOURCES LTD

10-K March 12, 2026

Key Highlights

Flagship Bear Lodge REE Project in Wyoming aims to be a critical domestic source...
Proprietary, environmentally friendly, acid-free processing technology offers a ...
Strategic focus on developing a Demonstration Plant to validate technology, opti...

Read Analysis

🤖 AI Generated

Whitehawk Therapeutics, Inc.

10-K March 12, 2026

Key Highlights

Clinical-stage biopharmaceutical company focused on novel therapeutic candidates...
Leverages proprietary scientific platforms for drug discovery and development.
Operates as a 'smaller reporting company' under specific SEC disclosure requirem...

Read Analysis

🤖 AI Generated

Tonix Pharmaceuticals Holding Corp.

10-K March 12, 2026

Key Highlights

Advancing lead candidate TNX-102 SL in pivotal Phase 3 for fibromyalgia, with to...
Diverse pipeline targeting CNS and immunology, including a smallpox/monkeypox va...
Minimal long-term debt, relying on equity, which is common for development-stage...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage